Vericel Corp. buy melinda
Start price
11.01.11
/
50%
€49.92
Target price
11.07.11
€80.00
Performance (%)
-24.88%
End price
11.07.11
€37.50
Summary
This prediction ended on 11.07.11 with a price of €37.50. The prediction for Vericel Corp. disappointed with a performance of -24.88%. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Vericel Corp. | 2.073% | 2.073% | 22.360% | -10.046% |
iShares Core DAX® | -1.114% | 5.062% | 24.922% | 25.215% |
iShares Nasdaq 100 | 1.816% | 9.828% | 29.548% | 44.324% |
iShares Nikkei 225® | 2.113% | 8.218% | 22.231% | 12.395% |
iShares S&P 500 | 2.038% | 7.448% | 30.358% | 43.899% |
According to melinda what are the pros and cons of Vericel Corp. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread Vericel Corp. diskutieren
Cardiovascular Disease
AASTROMbiosciences gutes Jahr für astm Ich denke, sein Potenzial, der unangefochtene Marktführer in der Stammzellforschung poue Herz-Kreislauf-Erkrankung zu
(Laufzeit überschritten)
Stopped prediction by melinda for Vericel Corp.
Vericel Corp.
Start price
Target price
Perf. (%)
€30.20
19.08.23
19.08.23
-
19.08.24
19.08.24
40.40%
20.08.24
20.08.24
Could be worthwhile Investment >10% per year
Vericel Corp.
Start price
Target price
Perf. (%)
€10.85
11.03.20
11.03.20
€15.00
04.11.21
04.11.21
288.94%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Vericel Corp.
Start price
Target price
Perf. (%)
€4.42
07.10.17
07.10.17
€5.41
03.01.18
03.01.18
20.41%
03.01.18
03.01.18
Could be worthwhile Investment >10% per year
Vericel Corp.
Start price
Target price
Perf. (%)
€2.85
23.04.16
23.04.16
€4.96
24.10.16
24.10.16
-22.47%
24.10.16
24.10.16
Could be worthwhile Investment >10% per year
Vericel Corp.
Start price
Target price
Perf. (%)
€11.74
01.04.13
01.04.13
€14.00
01.10.13
01.10.13
-70.70%
01.10.13
01.10.13
Could be worthwhile Investment >10% per year